OncRef

Clinical Trial: NCT06179732

Field Evaluations of Innovative Tools for Vector-borne Disease Control in Conflict-affected Communities

Status:

COMPLETED

Phase:

Phase 3

Lead Sponsor:The Mentor Initiative
Information Provided By:The Mentor Initiative
Last Update Posted:2024-04-23

Study Overview

Brief Summary

The aim of this study is to determine the effectiveness of a new spatial repellent (called Mesh) at repelling multiple disease vectors and, reducing clinical malaria rates in temporary shelters and camp settings. The design of the study will be a two-armed cluster randomised trial.

By conducting the research in challenging camp settings in the north of Nigeria, the MENTOR Initiative aims to determine whether Mesh can be effective in harsh camp conditions where communities are living in conflict area temporary shelters.

Official Title

Field Evaluations of Innovative Tools for Vector-borne Disease Control in Conflict-affected Communities:A Cluster Randomised Trial

Conditions

Malaria, Childhood ALL, Vector Borne Diseases

Intervention / Treatment

  • Combination Product: Mesh - spatial repellent impregnated with transfluthrin (2500mg)
  • Behavioral: Information and Education Campaigns (IEC)
  • Diagnostic Test: test and treat malaria cases

Other Study ID Numbers

  • USDA01YEM - Nigeria

Start Date (Actual)

2023-06-05

Primary Completion Date (Actual)

2023-12-31

Study Completion Date (Actual)

2023-12-31

Enrollment (Actual)

2400

Study Type

Interventional

Phase

Phase 3